Clinical Relevance and Prevalence of Polymorphisms in CYP3A5 and MDR1 Genes That Encode Tacrolimus Biotransformation Enzymes in Liver Transplant Recipients

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

Peter Kuehl, Jiong Zhang, Yvonne Lin et al. · Nature Genetics · 2001 · 2.2K citations

Life Sciences, Genetics, Molecular Biology +17

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

Dennis A. Hesselink · Clinical Pharmacology & Therapeutics · 2003 · 653 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirement

Iain MacPhee, Salim Fredericks, Tracy W Tai et al. · Transplantation · 2002 · 314 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Modulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein <i>MDR1</i> gene

Andreas Johne, Karla Köpke, Thomas Gerloff et al. · Clinical Pharmacology & Therapeutics · 2002 · 306 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +14

CYP3A5*1-carrying graft liver reduces the concentration/oral dose ratio of tacrolimus in recipients of living-donor liver transplantation

Maki Goto, Satohiro Masuda, Tetsuya Kiuchi et al. · Pharmacogenetics · 2004 · 190 citations

Pharmacy, Pharmacokinetics, Pharmacology +17